Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set
Abstract Background Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there is heterogeneity in the outcomes used acro...
Main Authors: | Nicola L. Harman, John Wilding, Dave Curry, James Harris, Jennifer Logue, R. John Pemberton, Leigh Perreault, Gareth Thompson, Sean Tunis, Paula R. Williamson, on behalf of the SCORE-IT study team |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-018-2805-2 |
Similar Items
-
SCORE-IT (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes): a systematic review of registered trials
by: Nicola L. Harman, et al.
Published: (2017-12-01) -
Core Outcome Set-STAndards for Development: The COS-STAD recommendations.
by: Jamie J Kirkham, et al.
Published: (2017-11-01) -
Impact of question order on prioritisation of outcomes in the development of a core outcome set: a randomised controlled trial
by: Sara T. Brookes, et al.
Published: (2018-01-01) -
Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement
by: Jamie J. Kirkham, et al.
Published: (2019-02-01) -
Core Outcome Set-STAndards for Reporting: The COS-STAR Statement.
by: Jamie J Kirkham, et al.
Published: (2016-10-01)